Wai Keen Chung
About Wai Keen Chung
Wai Keen Chung is the Associate Director at Bristol Myers Squibb in Devens, Massachusetts, with extensive experience in purification process sciences and a diverse educational background from Rensselaer Polytechnic Institute and UCL.
Current Position at Bristol Myers Squibb
Wai Keen Chung currently holds the position of Associate Director at Bristol Myers Squibb. Located in Devens, Massachusetts, this role capitalizes on his extensive background in the biopharmaceutical industry, specifically in purification process sciences. His responsibilities include overseeing various projects and leading initiatives aimed at optimizing processes within the organization.
Past Experience at Biogen and Ultragenyx Pharmaceutical Inc.
Before joining Bristol Myers Squibb, Wai Keen Chung served as an Associate Director at Ultragenyx Pharmaceutical Inc. for 7 months, from 2021 to 2022. Prior to that, he worked at Biogen as Senior Engineer III, from 2019 to 2021, located in Cambridge, Massachusetts. These roles further honed his expertise in the biopharmaceutical sector, contributing to his professional growth and leadership skills.
Career at MedImmune
Wai Keen Chung spent a significant part of his career at MedImmune, serving in multiple capacities within the Purification Process Sciences department. He started as a Scientist I, Late Stage Purification, from 2009 to 2013. Following this, he held roles as Scientist II and Senior Scientist until 2019. His tenure at MedImmune highlights his deep expertise in purification processes and his ability to handle progressively complex scientific responsibilities.
Academic Background
Wai Keen Chung pursued his higher education at Rensselaer Polytechnic Institute, where he was a graduate student from 2003 to 2009. His academic journey also includes studies at UCL. This diverse educational background laid the foundation for his extensive career in the biopharmaceutical industry.
Work in the US and the UK
Throughout his career, Wai Keen Chung has gained experience working in both the United States and the United Kingdom. This international exposure has contributed to his versatile understanding of the global biopharmaceutical landscape. His roles at various esteemed organizations reflect a trajectory of professional advancement from scientific roles to leadership positions.